Early research (Phase 1)Study completedNCT03371004What this trial is testingDM-CHOC-PEN Plus Radiation for Brain TumorsWho this might be right forAdvanced Cancer DEKK-TEC, Inc. 19
Testing effectiveness (Phase 2)UnknownNCT04827004What this trial is testingAnlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT00061815What this trial is testingStudy of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal CancerWho this might be right forColorectal Cancer Eli Lilly and Company 102
Large-scale testing (Phase 3)Study completedNCT02234115What this trial is testingSafety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate CarcinomaWho this might be right forProstatic Neoplasms Foresee Pharmaceuticals Co., Ltd. 137
Testing effectiveness (Phase 2)Study completedNCT00318136What this trial is testingBevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)Who this might be right forNon-small Cell Lung Cancer Genentech, Inc. 47
Early research (Phase 1)Looking for participantsNCT05945849What this trial is testingCD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AMLWho this might be right forLeukemia, Myeloid, Acute University of Pennsylvania 16
Large-scale testing (Phase 3)Ended earlyNCT00109538What this trial is testingStudy of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)Who this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicMyelodysplasia+1 more Merck Sharp & Dohme LLC 47
Not applicableLooking for participantsNCT07465848What this trial is testingProspective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer DiagnosisWho this might be right forLung Cancer (Diagnosis)Health Adult SubjectsPatient Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe) 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT05636215What this trial is testingA First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Innovent Biologics (Suzhou) Co. Ltd. 368
Early research (Phase 1)Study completedNCT02215850What this trial is testingSafety Study of SLC-0111 in Subjects With Advanced Solid TumoursWho this might be right forSolid Tumours Welichem Biotech Inc. 24
Large-scale testing (Phase 3)Study completedNCT00652938What this trial is testingEvaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female SubjectsWho this might be right forInfections, Papillomavirus GlaxoSmithKline 744
Testing effectiveness (Phase 2)Ended earlyNCT02162758What this trial is testingEffect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency AblationWho this might be right forBarrett's Esophagus Takeda 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02671435What this trial is testingDurvalumab (MEDI4736) and Monalizumab in Solid TumorsWho this might be right forAdvanced Solid Tumors MedImmune LLC 383
Testing effectiveness (Phase 2)Looking for participantsNCT05970497What this trial is testingA Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid TumorsWho this might be right forCancerMelanoma Stage IIIMelanoma Stage IV+1 more Krystal Biotech, Inc. 240
Early research (Phase 1)Study completedNCT01229618What this trial is testingHyperpolarized Pyruvate Injection in Subjects With Prostate CancerWho this might be right forProstate Cancer University of California, San Francisco 31
Testing effectiveness (Phase 2)Looking for participantsNCT06758882What this trial is testingSurgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PETWho this might be right forHigh Risk Prostate Cancer Marco Oderda 94
Early research (Phase 1)Study completedNCT02055716What this trial is testingSulforadex in Healthy Human Males MADWho this might be right forProstate Cancer Evgen Pharma 18
Testing effectiveness (Phase 2)Looking for participantsNCT07024784What this trial is testingAssess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other TherapiesWho this might be right forGynecologic CancersPlatinum-Sensitive Ovarian CancerFallopian Tube Cancer+1 more AbbVie 377
Testing effectiveness (Phase 2)Ended earlyNCT00570258What this trial is testingRandomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal TherapyWho this might be right forMetastatic Breast Cancer University of Arkansas 27
Early research (Phase 1)Not Yet RecruitingNCT06823258What this trial is testingPharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic FunctionWho this might be right forNSCLC (advanced Non-small Cell Lung Cancer) Jiangsu Hansoh Pharmaceutical Co., Ltd. 32